National Center for Advancing Translational Sciences
E16877
U.S. federal research agency
biomedical research center
institute of the National Institutes of Health
The National Center for Advancing Translational Sciences is a U.S. biomedical research center focused on accelerating the development and delivery of new diagnostics, treatments, and cures by improving the translational science process.
Aliases (3)
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
U.S. federal research agency
→
biomedical research center → institute of the National Institutes of Health → |
| abbreviation |
NCATS
→
|
| country |
United States
→
|
| employerOf |
translational science researchers
→
|
| field |
biomedical research
→
clinical research → drug development → rare diseases research → translational science → |
| focus |
accelerating the development of new cures
→
accelerating the development of new diagnostics → accelerating the development of new treatments → improving the translational science process → |
| foundedBy |
National Institutes of Health
→
|
| fundingSource |
U.S. federal budget
→
|
| goal |
reduce the cost of developing new medical products
→
reduce the failure rate of new diagnostics and therapeutics → reduce the time it takes for laboratory discoveries to become treatments for patients → |
| hasPart |
Cures Acceleration Network
→
Division of Clinical Innovation → Division of Pre-Clinical Innovation → Office of Rare Diseases Research → |
| headquartersLocation |
Bethesda, Maryland
→
|
| inception |
2011
→
|
| jurisdiction |
federal government of the United States
→
|
| language |
English
→
|
| location |
Bethesda, Maryland
→
Maryland → United States → |
| mission |
to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster
→
|
| operates |
Bridging Interventional Development Gaps program
→
Clinical and Translational Science Awards Program → NCATS Chemical Genomics Center → Rare Diseases Clinical Research Network → Small Business Innovation Research program → Small Business Technology Transfer program → Therapeutics for Rare and Neglected Diseases program → Toxicology in the 21st Century program → |
| parentOrganization |
U.S. Department of Health and Human Services
→
|
| partOf |
National Institutes of Health
→
|
| researchFocus |
biomarker development
→
drug repurposing → improving clinical trial efficiency → methods and technologies that cut across diseases and conditions → patient engagement in research → |
| website |
https://ncats.nih.gov
→
|
Referenced by (14)
| Subject (surface form when different) | Predicate |
|---|---|
|
Clinical and Translational Science Awards Program
("National Center for Advancing Translational Sciences programs")
→
Division of Pre-Clinical Innovation → Division of Pre-Clinical Innovation ("NCATS") → Office of Rare Diseases Research → Therapeutics for Rare and Neglected Diseases program → |
partOf |
|
National Center for Advancing Translational Sciences
("NCATS")
→
National Center for Advancing Translational Sciences ("NCATS") → |
abbreviation |
|
Clinical and Translational Science Awards Program
→
Therapeutics for Rare and Neglected Diseases program → |
operatedBy |
|
Cures Acceleration Network
→
|
administeredBy |
|
National Institutes of Health
→
|
hasPart |
|
Office of Rare Diseases Research
→
|
movedTo |
|
National Center for Advancing Translational Sciences
("NCATS Chemical Genomics Center")
→
|
operates |
|
Division of Pre-Clinical Innovation
→
|
parentOrganization |